Pulse Biosciences, Inc. (PLSE) Operating cash flow 2016–2025
Pulse Biosciences, Inc. (PLSE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.1MFY2025 · since FY2016: -$8.1M → -$54.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.1M | -48.9% |
| FY2024 | -$36.3M | -10.0% |
| FY2023 | -$33.0M | +29.7% |
| FY2022 | -$47.0M | +13.1% |
| FY2021 | -$54.1M | -53.0% |
| FY2020 | -$35.4M | -3.5% |
| FY2019 | -$34.2M | -43.1% |
| FY2018 | -$23.9M | -115.5% |
| FY2017 | -$11.1M | -37.7% |
| FY2016 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice